NCT04478695 2024-03-08
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
Amgen
Phase 1 Terminated
Clinical Trials
3 trialsNCT03144245 2021-10-12
Study of AMV564 in Patients With AML
Amphivena Therapeutics, Inc.
Phase 1 Completed
NCT03605589 2021-04-01
Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma
Children's Hospital Medical Center, Cincinnati
Phase 1 Withdrawn